Most a short while ago, it's been identified that conolidine and the above derivatives act around the atypical chemokine receptor 3 (ACKR3. Expressed in equivalent areas as classical opioid receptors, it binds to some big selection of endogenous opioids. Compared with most opioid receptors, this receptor functions being a scavenger and will not act